Preview

Russian Ophthalmological Journal

Advanced search

Malignant eyelid tumors: epidemiology and clinical observation of patients in Moscow

https://doi.org/10.21516/2072-0076-2022-15-4-38-44

Abstract

Purpose: to assess the prevalence of primary malignant eyelid tumors and their prognostic features based on the materials of the ocular oncology department, Moscow Ophthalmological Center. Materials and methods. We performed a retrospective analysis of 10-year array (2010–2019) of documents of the Moscow Cancer Register, reports of the ocular oncology department of the Moscow ophthalmological center, S.P. Botkin State Clinical Hospital, and case histories of outpatients with malignant eyelid tumors, residing in Moscow. Results. Malignant ocular tumors were diagnosed in 3650 people. Of these, 75.29 % were eyelid tumors (2748 people). The most common malignant tumor was basal cell carcinoma (89.19 %), which was morphologically diagnosed and over the ten years showed an incidence increase of almost a third. The occurrence rate grows with age, with the peak observed between 70 and 79 years of life. Most often, the lower eyelid (64%) and the inner corner (22.14 %) are affected. Less common are tumors located in the upper eyelid (12.21 %) and at the lateral canthus — 2.3 %. Over 80 % of the relapses occurred at the T2–T3 stages, while only 18.2 % were eyelid skin cancers treated at the T1 stage. Tumors located in the inner corner of the palpebral fissure recurred up to 3 times more often than differently localized eyelid tumors. Conclusion. Malignant eyelid tumors are the most common of malignant ocular neoplasms, claiming ¾ of them. Basal cell carcinoma is the most common type. The peak incidence falls upon the 7th and the 8th decades of life. An increase in the incidence of malignant tumors of the eyelids is observed. The special ophthalmic-oncological service facilitates the diagnostics, treatment and dispensary observation of patients after treatment, which contributes to the early detection of relapses.

About the Authors

M. Yu. Lerner
S.P. Botkin State Clinical Hospital, Moscow Ophthalmological Center
Russian Federation

Marina Yu. Lerner — Cand. of Med. Sci., head of ocular oncology department

Moscow, 2nd Botkinsky Dr., Bldg. 5, 125284



O. N. Steshenko
S.P. Botkin State Clinical Hospital, Moscow Ophthalmological Center
Russian Federation

Olga N. Steshenko — Cand. of Med. Sci., ophthalmologist, ocular oncology department

Moscow, 2nd Botkinsky Dr., Bldg. 5, 125284



References

1. Pornpanich K., Chindasub P. Eyelid tumors in Siriraj Hospital from 2000-2004. J. Med. Assoc. Thai. 2005; 88 (9): 11–4.

2. Wang L., Shan Y., Dai X., et al. Clinicopathological analysis of 5146 eyelid tumors and tumor-like lesions in an eye center in South China, 2000–2018: a retrospective cohort study. BMJ Open. 2021; 11 (1): e041854. doi:10.1136/bmjopen-2020-041854

3. Mercut I.M., Ilia L.C., Tanasie C.A., et al. Analysis of tumors related data and clinical features of eyelid carcinomas. Curr. Health Sci. J. 2020; 46 (3): 222–9. doi:10.12865/CHSJ.46.03.02

4. Panova I.E., Vazhenin A.V., Usova R.A., Voytanik G.F., Kurenkov E.L. Epidemiology, clinical and morphological characteristics, differential diagnosis of basal cell carcinoma of the eyelid skin. Chelyabinsk: Ural State Medical Academy of Additional Education; 2003 (in Russian).

5. Cook Jr.B.E., Bartley G.B. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. Ophthalmology. 2001; 108 (11): 2088–98. doi:10.1016/s0161-6420(01)00796-5

6. Murchison A.P., Walrath J.D., Washington C.V. Non-surgical treatments of primary, non-melanoma eyelid malignancies: a review. Clin. Exp. Ophthalmol. 2011; 39 (1): 65–83. doi:10.1111/j.1442-9071.2010.02422.x

7. Actis A.G., Actis G., De Sanctis U., et al. Eyelid benign and malignant tumors: issues in classification, excision and reconstruction. Minerva Chir. 2013; 68 (6 Suppl 1): 11–25.

8. Martens M.C., Seebode C., Lenmann J., Emmert S. Photocarcinogenesis and skin cancer prevention strategies: an update anticancer research. 2018; 38 (2): 1153–8. doi:10.21873/anticanres.12334

9. Marzuka A.G., Book S.E. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J. Biol. Med. 2015 Jun; 88 (2): 167–79. PMID: 26029015

10. Mittal A., Colegio O.R. Skin cancers in organ transplant recipients. Am. J. Transplant. 2017; 17 (10): 2509–30. doi:10.1111/ajt.14382

11. Asproudis I., Sotiropoulos G., Gartzios C., et al. Eyelid tumors at the university eye clinic of Ioannina, Greece: A 30-year retrospective study. Middle East Afr. J. Ophthalmol. 2015; 22 (2): 230–2. doi:10.4103/0974-9233.151881

12. Cook Jr.B.E., Bartley G.B. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota. Ophthalmology. 1999; 106 (4): 746–50. doi:10.1016/S0161-6420(99)90161-6.

13. Rene C. Oculoplastic aspects of ocular oncology. Eye (Lond). 2013; 27 (2): 199–207. doi:10.1038/eye.2012.243

14. Paavilainen V., Tuominen J., Pukkala E., Saari K.M. Basal cell carcinoma of the eyelid in Finland during 1953-97. Acta Ophthalmol. Scand. 2005; 83 (2): 215–20. doi:10.1111/j.1600-0420.2005.00445.x

15. Huang Y-Y., Liang W-Y., Tsai C-C., et al. Comparison of the clinical characteristics and outcome of benign and malignant eyelid tumors: An analysis of 4521 eyelid tumors in a tertiary medical center. Biomed. Res. Int. 2015; 2015: 453091. doi:10.1155/2015/453091

16. Kaliki S., Bothra N., Bejjanki K.M., et al. Malignant eyelid tumors in India: a study of 536 Asian Indian patients. Ocul. Oncol. Pathol. 2019 5 (3): 210–9. doi:10.1159/000491549

17. Mercut I-M., Ilia L-C., Tanasie C-A., et al. Analysis of tumour related data and clinical features of eyelid carcinomas. Curr. Health Sci. J. 2020; 46 (3): 222–9. doi:10.12865/CHSJ.46.03.02

18. Dias M.R., Osaki M.H., Ferreira C.A.A., et al. Epidemiological profile and clinical stage at presentation of eyelid malignancies in a multi-ethnic country. J. Craniofac. Surg. 2021; 32 (7): e642–5. doi:10.1097/SCS.0000000000007649

19. Quigley C., Deady S., Hughes E., et al. National incidence of eyelid cancer in Ireland. Eye (Lond). 2019; 33 (10): 1534–9. doi:10.1038/s41433-019-0437-8

20. Saari K.M., Paavilainen V., Tuominen J., Collan Y. Epidemiology of basal cell carcinoma of the eyelid in south-western Finland. Graefes Arch. Clin. Exp. Ophthalmol. 2001; 239 (3): 230–3. doi:10.1007/s004170100260

21. Lee S., Saw S., Eong K., Chan T., Lee H. Incidence of eyelid cancers in Singapore from 1968 to 1995. Br. J. Ophthalmol. 1999; 83 (5): 595–7. doi:10.1136/bjo.83.5.595

22. Bagheri A., Tavakoli M., Kanaani A., et al. Eyelid masses: a 10-year survey from a tertiary eye hospital in Tehran. Middle East Afr. J. Ophthalmol. 2013; 20 (3): 187–92. doi:10.4103/0974-9233.114788


Review

For citations:


Lerner M.Yu., Steshenko O.N. Malignant eyelid tumors: epidemiology and clinical observation of patients in Moscow. Russian Ophthalmological Journal. 2022;15(4):38-44. (In Russ.) https://doi.org/10.21516/2072-0076-2022-15-4-38-44

Views: 708


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2072-0076 (Print)
ISSN 2587-5760 (Online)